10x Insights
Loading account…
Companies / Consumer Staples / SOLESENCE, INC.
SLSN

SOLESENCE, INC.

Consumer StaplesPersonal Care
Ticker SLSNROMEOVILLE, ILFiscal year ends DecemberBook value per share $0.19Diluted shares 70.6M

Solésence, Inc. (NASDAQ: SLSN) is a science-driven health and wellness company specializing in skin health innovation and engineered materials for beauty, personal care, and advanced applications. The company operates under the website ir.solesence.com and maintains development, testing, and manufacturing facilities… From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$62.06M
+18.6% year over year
Last 12 mo $55.37M
2.53%
−7.3 percentage points
Last 12 mo -2.12%
$1.79M
−57.7% year over year
Last 12 mo $-2.08M
10.15%
−18.2 percentage points
Last 12 mo -15.79%
Cash & financing
$-8.57M
−534.7% year over year
Last 12 mo $1.02M
$-8.57M
−231.2% year over year
Last 12 mo $1.02M
0.87
Was 0.33× a year earlier
Last 12 mo 1.09
72.6M
+11.6% year over year
Last 12 mo 70.6M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What SOLESENCE, INC. does

In the company’s own words

Solésence, Inc. (NASDAQ: SLSN) is a science-driven health and wellness company specializing in skin health innovation and engineered materials for beauty, personal care, and advanced applications. The company operates under the website ir.solesence.com and maintains development, testing, and manufacturing facilities in the Chicago, Illinois area.

The company operates through three primary product categories. Consumer products represent the largest revenue segment at 88 percent of total revenue, consisting of fully formulated finished cosmetic products including skin care, sun care, and color cosmetics marketed under proprietary technology platforms. The Active Stress Defense family of technologies, including Solésence Kleair, provides mineral-based UV protection, pollution protection, and blue light protection across multiple product formats. Personal care ingredients comprise approximately 10 percent of revenue and include surface-engineered zinc oxide and titanium dioxide sold as active pharmaceutical ingredients to major global consumer products companies for sunscreens and skin health applications. Advanced materials represent the remaining revenue from legacy applications in medical diagnostics, architectural coatings, and industrial uses.

Solésence employs 115 full-time employees plus 90 to 225 temporary and temporary-to-permanent workers on a demand-driven basis. The company operates two leased facilities in the Chicago suburbs: a 36,000 square-foot headquarters and research facility in Romeoville and a 261,000 square-foot production and warehouse facility in Bolingbrook. All manufacturing processes comply with FDA current Good Manufacturing Practice standards and are registered under ISO 9001, ISO 22716, and ISO 14001 certifications.

The company's competitive advantages stem from proprietary particle coating and dispersion technologies enabling the creation of engineered materials at nano and non-nano scales. The vertically integrated business model allows simultaneous development of ingredient technologies and finished formulations. Solésence has developed and commercialized over 950 SKUs of finished cosmetic products and maintains long-term relationships with major customers including BASF Corporation. The company holds 11 U.S. patents and 123 foreign patents and applications focused on health and wellness applications. Originally incorporated in Illinois in 1989 and rebranded from Nanophase Technologies Corporation in March 2025, Solésence sells consumer products to brand partners in prestige and mass beauty markets rather than directly to consumers.

Company details
Sector
Consumer Staples
Industry
Personal Care
Headquarters
ROMEOVILLE, IL
Fiscal year end
December
CIK
883107
SIC
2844

Financial performance, year by year

Fiscal 2013–2025 · USD
$-11.04M$8.90M$28.84M$48.77M$68.71M2013201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns SOLESENCE, INC. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

44
funds hold it
0 of 35
superinvestors hold it
$1.51M
held by funds, at market
2.3%
of shares held by funds

Largest fund holders · SOLESENCE, INC.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
Fidelity Small Cap Index Fund
FSSNX · Fidelity Salem Street Trust
0.00%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets
VANGUARD RUSSELL 2000 INDEX FUND
VTWO · VANGUARD SCOTTSDALE FUNDS
0.00%of fund net assets
Fidelity Extended Market Index Fund
FSMAX · Fidelity Concord Street Trust
0.00%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do SOLESENCE, INC. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of SOLESENCE, INC.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in SOLESENCE, INC.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.